ANI Pharmaceuticals Launches Generic Cymbalta

MT newswire2026/10/19 11:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

07:32 AM EDT, 10/19/2026 (MT Newswires) -- ANI Pharmaceuticals (ANIP) launched generic duloxetine delayed-release capsules in 20 mg, 30 mg and 60 mg, offering an alternative to Eli Lilly's (LLY) Cymbalta, the drugmaker said Monday. The launch expands access to a widely used treatment in a market with limited competition, ANI said. US annual sales of duloxetine delayed-release capsules, a treatment for major depressive disorder in adults, reached about $247 million, based on IQVIA data for the 12 months ended August, ANI said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.

华尔街见闻•2026/11/06 23:26